Neuphoria Therapeutics (NEUP) Financial Statements

Neuphoria Therapeutics's market cap is currently $9.95M. The company's EPS TTM is $-0.062; its P/E ratio is -0.18; Neuphoria Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.